-
Proteome and transcriptome analysis reveals tubulin isotype switching in paclitaxel-treated esophageal cancer
Veen, L. M., van der Zalm, A. P., Blangé, D., Manoukian, P., van Mourik, M., de Goeij-de Haas, R. R., Piersma, S. R., Pham, T. V., Jimenez, C. R., Meijer, S. L., van Laarhoven, H. W. & Bijlsma, M. F., 1 Dec 2025, In: ESMO Gastrointestinal Oncology. 10, 100237.Research output: Contribution to journal › Article › Academic › peer-review
-
The pluripotency factor NANOG contributes to mesenchymal plasticity and is predictive for outcome in esophageal adenocarcinoma
van der Zalm, A. P., Dings, M. P. G., Manoukian, P., Boersma, H., Janssen, R., Bailey, P., Koster, J., Zwijnenburg, D., Volckmann, R., Bootsma, S., Waasdorp, C., van Mourik, M., Blangé, D., van den Ende, T., Oyarce, C. S. I., Derks, S., Creemers, A., Ebbing, E. A., Hooijer, G. K. & Meijer, S. L. & 4 others, , 1 Dec 2024, In: Communications medicine. 4, 1, 89.Research output: Contribution to journal › Article › Academic › peer-review
-
Resistance mechanisms to HER2-targeted therapy in gastroesophageal adenocarcinoma: A systematic review
Blangé, D., Stroes, C. I., Derks, S., Bijlsma, M. F. & van Laarhoven, H. W. M., 1 Jul 2022, In: Cancer Treatment Reviews. 108, 102418.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications
